288.29
price down icon1.47%   -4.31
after-market 시간 외 거래: 288.30 0.010 +0.00%
loading
전일 마감가:
$292.60
열려 있는:
$292.56
하루 거래량:
1.06M
Relative Volume:
0.84
시가총액:
$55.88B
수익:
$316.65B
순이익/손실:
$1.91B
주가수익비율:
29.66
EPS:
9.72
순현금흐름:
$1.14B
1주 성능:
-0.71%
1개월 성능:
-0.71%
6개월 성능:
+15.07%
1년 성능:
+21.26%
1일 변동 폭
Value
$287.79
$293.81
1주일 범위
Value
$287.79
$306.28
52주 변동 폭
Value
$218.65
$309.35

Cencora Inc Stock (COR) Company Profile

Name
명칭
Cencora Inc
Name
전화
610-727-7000
Name
주소
1 WEST FIRST AVENUE, CONSHOHOCKEN
Name
직원
46,000
Name
트위터
Name
다음 수익 날짜
2024-11-06
Name
최신 SEC 제출 서류
Name
COR's Discussions on Twitter

COR을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Distribution icon
COR
Cencora Inc
288.23 56.29B 316.65B 1.91B 1.14B 9.72
Medical Distribution icon
MCK
Mckesson Corporation
679.39 83.49B 377.60B 3.35B 5.67B 25.08
Medical Distribution icon
CAH
Cardinal Health Inc
146.00 35.75B 222.58B 1.57B 1.85B 6.45
Medical Distribution icon
HSIC
Henry Schein Inc
68.47 8.15B 12.50B 314.00M 421.00M 2.44
Medical Distribution icon
AHG
Akso Health Group Adr
1.77 701.93M 2.22M -5.63M -1.68M -0.24

Cencora Inc Stock (COR) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-03 업그레이드 Wells Fargo Equal Weight → Overweight
2024-12-04 재개 Mizuho Outperform
2024-09-18 다운그레이드 BofA Securities Buy → Neutral
2024-02-26 개시 Leerink Partners Outperform
2024-01-03 개시 Barclays Overweight
2023-12-14 개시 Wells Fargo Equal Weight
2023-03-31 개시 Citigroup Buy
2023-01-31 재개 Evercore ISI Outperform
2022-10-11 업그레이드 BofA Securities Neutral → Buy
2022-08-22 재개 Morgan Stanley Equal-Weight
2022-07-11 다운그레이드 Evercore ISI Outperform → In-line
2022-06-07 업그레이드 Deutsche Bank Hold → Buy
2022-05-26 업그레이드 Barclays Equal Weight → Overweight
2022-04-12 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2022-04-01 재개 Credit Suisse Outperform
2021-03-12 재개 Evercore ISI In-line
2021-02-04 업그레이드 Evercore ISI In-line → Outperform
2021-02-02 업그레이드 Cowen Market Perform → Outperform
2021-01-06 업그레이드 BofA Securities Underperform → Neutral
2021-01-06 업그레이드 Credit Suisse Neutral → Outperform
2020-12-10 다운그레이드 Wells Fargo Equal Weight → Underweight
2020-12-03 개시 Mizuho Neutral
2020-08-06 업그레이드 Raymond James Mkt Perform → Outperform
2020-07-15 개시 Barclays Underweight
2020-06-15 업그레이드 Morgan Stanley Equal-Weight → Overweight
2020-04-23 재개 Credit Suisse Outperform
2020-04-16 다운그레이드 Raymond James Outperform → Mkt Perform
2020-04-13 다운그레이드 Robert W. Baird Outperform → Neutral
2020-04-01 업그레이드 JP Morgan Neutral → Overweight
2020-03-17 업그레이드 Citigroup Neutral → Buy
2020-02-11 다운그레이드 BofA/Merrill Buy → Underperform
2020-02-07 업그레이드 Robert W. Baird Neutral → Outperform
2019-09-12 개시 Deutsche Bank Hold
2019-07-10 다운그레이드 KeyBanc Capital Markets Overweight → Sector Weight
2019-04-11 개시 Guggenheim Buy
2019-04-10 다운그레이드 BofA/Merrill Buy → Underperform
2019-04-10 다운그레이드 Evercore ISI Outperform → In-line
2019-02-11 다운그레이드 JP Morgan Neutral → Underweight
2019-01-17 개시 UBS Buy
2018-12-10 다운그레이드 Jefferies Buy → Hold
2018-10-26 다운그레이드 RBC Capital Mkts Outperform → Sector Perform
2018-09-20 개시 Berenberg Buy
2018-07-17 재개 Stifel Hold
2018-04-09 개시 MoffettNathanson Buy
2018-03-12 업그레이드 KeyBanc Capital Mkts Sector Weight → Overweight
2018-03-12 업그레이드 Raymond James Mkt Perform → Outperform
2017-09-25 개시 JP Morgan Neutral
2017-09-22 개시 William Blair Outperform
모두보기

Cencora Inc 주식(COR)의 최신 뉴스

pulisher
Aug 20, 2025

Cencora Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 20, 2025
pulisher
Aug 20, 2025

Published on: 2025-08-21 02:56:19 - classian.co.kr

Aug 20, 2025
pulisher
Aug 20, 2025

Cencora directors ink $111M deal related to opioid claims - MSN

Aug 20, 2025
pulisher
Aug 20, 2025

Cencora Inc. Rebound Backed by Sentiment ShiftWeekly Market Report & Safe Investment Capital Preservation Plans - kangso.co.kr

Aug 20, 2025
pulisher
Aug 19, 2025

Cencora Posts Modest 1.5 Gain as Volume Plunge Sends Stock to 405th Trading Rank Amid Sector Restructuring Focus - AInvest

Aug 19, 2025
pulisher
Aug 18, 2025

What makes Cencora Inc. stock price move sharplyJuly 2025 Reactions & Verified Entry Point Signals - newsyoung.net

Aug 18, 2025
pulisher
Aug 18, 2025

Cencora directors settle opioid claims for $111M - AInvest

Aug 18, 2025
pulisher
Aug 16, 2025

Cencora directors ink $111M opioid deal (COR:NYSE) - Seeking Alpha

Aug 16, 2025
pulisher
Aug 15, 2025

Cencora Shares Dip 0.70% as $320M Volume Ranks 332nd Amid Strategic Shifts and Sector Volatility - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

$111.25M Del. Settlement Proposed For Cencora Opioid Suits - Law360

Aug 15, 2025
pulisher
Aug 15, 2025

Cencora Directors Settle Opioid Claims for $111 Million - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Cencora Directors Reach $111 Million Deal on Opioid Claims - Bloomberg.com

Aug 15, 2025
pulisher
Aug 15, 2025

Why Cencora (COR) is a Top Value Stock for the Long-Term - Yahoo Finance

Aug 15, 2025
pulisher
Aug 14, 2025

Cencora’s 1.32% Rally Amid 295th-Ranked $350M Volume as Industry Navigates Regulatory Shifts and Profit Volatility - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Cencora Inc. Tests 50 Day MA After Sharp DeclineWeekly Stock Analysis & Stock Portfolio Risk Control - newsyoung.net

Aug 14, 2025
pulisher
Aug 14, 2025

Will Cencora Inc. stock go up in YEARMarket Performance Report & Community Verified Watchlist Alerts - newsimpact.co.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Short Term Trend Reversal in Cencora Inc. PossibleJuly 2025 Catalysts & High Accuracy Buy Signal Tips - thegnnews.com

Aug 14, 2025
pulisher
Aug 13, 2025

Cencora (COR) Stock Surpasses Market Gains with Strong PerformanceNews and Statistics - IndexBox

Aug 13, 2025
pulisher
Aug 13, 2025

Ex-Dividend Reminder: Cencora, Organon and Esquire Financial Holdings - Nasdaq

Aug 13, 2025
pulisher
Aug 13, 2025

Cencora Stock: Analyst Estimates & Ratings - Yahoo Finance

Aug 13, 2025
pulisher
Aug 13, 2025

Wells Fargo raises Cencora stock price target to $354 on strong U.S. Healthcare performance - Investing.com

Aug 13, 2025
pulisher
Aug 13, 2025

Cencora price target raised to $354 from $337 at Wells Fargo - TipRanks

Aug 13, 2025
pulisher
Aug 13, 2025

Stock Analysis | Cencora OutlookMixed Signals as Technicals and Analysts Diverge - AInvest

Aug 13, 2025
pulisher
Aug 12, 2025

Cencora Plummets 0.53% Amid Regulatory Scrutiny Ranks 189th in $580M Trading Volume Despite Sector Resilience - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Investors Still Waiting For A Pull Back In Cencora, Inc. (NYSE:COR) - 富途牛牛

Aug 12, 2025
pulisher
Aug 12, 2025

Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap (NYSE:COR) - Seeking Alpha

Aug 12, 2025
pulisher
Aug 12, 2025

Cencora (COR) Plummets 2.44% Amid Volatile Intraday Move: What’s Fueling the Selloff? - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Cencora Lifts Earnings Outlook After Strong Q3 Performance - MSN

Aug 12, 2025
pulisher
Aug 11, 2025

Cencora & The Lash Group Settle Data Breach Litigation for $40 Million - The HIPAA Journal

Aug 11, 2025
pulisher
Aug 11, 2025

Cencora (COR) Shares Jump 1.95% as Trading Volume Surges to $530M Ranking 184th in Market Activity - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

3 Reasons Growth Investors Will Love Cencora (COR) - Yahoo Finance

Aug 11, 2025
pulisher
Aug 10, 2025

RSI Suggests Rebound May Be Near in Cencora Inc.Top Gaining Picks With Entry Signals Identified - beatles.ru

Aug 10, 2025
pulisher
Aug 10, 2025

Is It Smart To Buy Cencora, Inc. (NYSE:COR) Before It Goes Ex-Dividend? - simplywall.st

Aug 10, 2025
pulisher
Aug 10, 2025

Why You Might Be Interested In Cencora, Inc. (NYSE:COR) For Its Upcoming Dividend - ca.finance.yahoo.com

Aug 10, 2025
pulisher
Aug 09, 2025

Published on: 2025-08-10 00:34:30 - metal.it

Aug 09, 2025
pulisher
Aug 09, 2025

Cencora, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - simplywall.st

Aug 09, 2025
pulisher
Aug 08, 2025

Cencora Rises 2.42% as Trading Volume Slumps to 313th Market Rank - AInvest

Aug 08, 2025
pulisher
Aug 08, 2025

Cencora Q3: Growing Specialty Drug Distributions; Initiate At Buy (NYSE:COR) - Seeking Alpha

Aug 08, 2025
pulisher
Aug 08, 2025

Research Alert: CFRA Raises View On Shares Of Cencora, Inc. To Buy From Hold - 富途牛牛

Aug 08, 2025
pulisher
Aug 08, 2025

Can Specialty and GLP-1 Momentum Support Cencora's Q3 Results? - MSN

Aug 08, 2025
pulisher
Aug 08, 2025

Cencora, Inc. Reports Strong Q3 2025 Financial Results - The Globe and Mail

Aug 08, 2025
pulisher
Aug 07, 2025

Cencora Reports Strong Q3 2025 Financial Results - The Globe and Mail

Aug 07, 2025
pulisher
Aug 07, 2025

Cencora: Fiscal Q3 Earnings Snapshot - New Haven Register

Aug 07, 2025
pulisher
Aug 07, 2025

Cencora (COR) Reports Q3 Earnings Growth, Maintains US$0.55 Dividend - simplywall.st

Aug 07, 2025
pulisher
Aug 06, 2025

Cencora’s Earnings Call: Strong Growth Amid Challenges - TipRanks

Aug 06, 2025
pulisher
Aug 06, 2025

Cencora Earnings: Solid Results Illustrate Healthy Demand and Stable Outlook; Shares Fairly Valued - Morningstar

Aug 06, 2025
pulisher
Aug 06, 2025

Cencora Says Famed GLP-1 Class Products Drive Growth, Boosts Profit Outlook - AOL.com

Aug 06, 2025
pulisher
Aug 06, 2025

Cencora Benefits From Strong GLP-1 Sales, Healthy Utilization Trends, and Growing Specialty Assets - Morningstar

Aug 06, 2025
pulisher
Aug 06, 2025

Cencora, Inc. SEC 10-Q Report - TradingView

Aug 06, 2025
pulisher
Aug 06, 2025

Cencora raises 2025 EPS guidance to $15.85–$16 and narrows outlook as specialty drives growth - MSN

Aug 06, 2025
pulisher
Aug 06, 2025

Cencora weakness after earnings ‘overdone,’ says Leerink - TipRanks

Aug 06, 2025

Cencora Inc (COR) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_distribution CAH
$146.00
price down icon 1.39%
medical_distribution MCK
$679.39
price down icon 1.46%
$68.47
price down icon 1.62%
medical_distribution AHG
$1.77
price up icon 0.00%
medical_distribution OMI
$5.13
price up icon 1.58%
자본화:     |  볼륨(24시간):